Skip to content
Stannsoporfin
Stannsoporfin is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
14 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Nutritional and metabolic diseasesD00975011
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HyperbilirubinemiaD006932325
Neonatal hyperbilirubinemiaD051556224
PorphyriasD011164EFO_0000665E80.20324
Neonatal jaundiceD007567P59.9112
Glucosephosphate dehydrogenase deficiencyD005955EFO_000728711
Fetal erythroblastosisD004899EFO_1000937P5511
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
JaundiceD007565HP_0000952R1711
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameSTANNSOPORFIN
INNstannsoporfin
Description
Stannsoporfin is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Classification
Small molecule
Drug classbenzoporphyrin derivatives
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID106344-20-1
RxCUI
ChEMBL IDCHEMBL4297207
ChEBI ID
PubChem CID
DrugBank
UNII ID0KAE1U0G7Q (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 7 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details